Long-Term Efficacy and Safety of Pediatric Prolonged-Release Melatonin for Insomnia in Children with Autism Spectrum Disorder

Objective: A recent double-blind randomized placebo-controlled study demonstrated 3-month efficacy and safety of a novel pediatric-appropriate prolonged-release melatonin (PedPRM) for insomnia in children and adolescents with autism spectrum disorder (ASD) and neurogenetic disorders (NGD) with/witho...

Descripción completa

Detalles Bibliográficos
Autores principales: Maras, Athanasios, Schroder, Carmen M., Malow, Beth A., Findling, Robert L., Breddy, John, Nir, Tali, Shahmoon, Shiri, Zisapel, Nava, Gringras, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mary Ann Liebert, Inc., publishers 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6306655/
https://www.ncbi.nlm.nih.gov/pubmed/30132686
http://dx.doi.org/10.1089/cap.2018.0020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6306655/
https://www.ncbi.nlm.nih.gov/pubmed/30132686
http://dx.doi.org/10.1089/cap.2018.0020

Ejemplares similares